RJA
NVIV

Raymond James & Associates’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Raymond James & Associates’s Portfolio NVIV Stock Details NVIV Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
2018
Q1 		$40K Hold
2017
Q4 		$61K Sell
2017
Q3 		$126K Buy
2017
Q2 		$139K Sell
2017
Q1 		$461K Buy
2016
Q4 		$344K Hold
2016
Q3 		$456K Buy
2016
Q2 		$174K Buy
2016
Q1 		$184K Buy